NEWS ABOUT CATAWBA RESEARCH

Catawba Research Announces Strategic Partnership With PharmaLegacy Laboratories

CHARLOTTE, N.C.; Oct. 22, 2024 (Business Wire) – Catawba Research, a leading global full-service Clinical Research Organization (CRO), is proud to announce a strategic partnership with PharmaLegacy Laboratories, a recognized leader in preclinical contract research services. This collaboration is set to leverage both companies’ strengths, driving innovation and excellence in drug development and provides Catawba Research with new access to China, further expanding their APAC capabilities.

Catawba Research Celebrates 10 Years of Excellence in Clinical Research: Marking a Decade of Innovation, Growth, and Commitment to Advancing Global Healthcare

Charlotte, N.C.; Sept. 26, 2024 (Business Wire) — Catawba Research , a global full-service Clinical Research Organization (CRO), is proud to announce its 10-year anniversary. Over the past decade, Catawba Research has es

Catawba Research Expands Scientific Advisory Board With Renowned Experts in Immunology and Dermatology

CHARLOTTE, N.C.; Aug. 22, 2024 (Business Wire) – Catawba Research , dedicated to becoming the world’s most trusted Contract Research Organization, announced the expansion of its Scientific Advisory Board (SAB) today with

Catawba Research Welcomes Tracy Hudson as New Head of Proposals

CHARLOTTE, N.C.; July 11, 2024 – Catawba Research , dedicated to becoming the world’s most trusted Contract Research Organization (CRO), is thrilled to announce the addition of Tracy Hudson as its new Vice President of P

Catawba Research Appoints Julie Arnold as New Head of Project Management to Drive Growth and Innovation

CHARLOTTE, N.C.; March 7, 2024 (Business Wire) – Catawba Research , a prominent global clinical research organization (CRO), today introduced Julie Arnold as its vice president of project management. The continued additi

Catawba Research Appoints Syed Faridi as New Head of Business Development

CHARLOTTLE, N.C.; Feb. 29, 2024 (Business Wire) – Catawba Research , a prominent global clinical research organization (CRO), welcomes Syed Faridi as its Vice President of Global Business Development. This strategic expa

Catawba Research Collaborates With Bingli Inc. to Make Patient Pre-Screening Easier for Participants and Sites

CHARLOTTE, N.C.; Feb. 6, 2024 – Catawba Research , a leading global clinical research organization (CRO) that has established itself as a trusted partner in the development of new drugs, devices, and diagnostics with a s

Catawba Research Partners With Elligo Health Research® to Expand Access and Simplify Clinical Research Participation

CHARLOTTE, N.C. ; Dec. 6, 2023 – Catawba Research , a leading global clinical research organization (CRO) that has established itself as a trusted partner in the development of new drugs and therapies, with a strong focu

Catawba Research Announces the Promotion of Andrew Silverman, Ph.D., to CEO

CHARLOTTE, N.C. ; Oct. 26, 2023 (Business Wire) — Catawba Research , a leading clinical research organization with a goal to become the world’s most trusted CRO, is announcing changes to its executive leadership team. Ef

CRO Catawba Research Names Andrew Silverman, Ph.D., as COO

CHARLOTTE, N.C.; March 30, 2023 – Catawba Research , a full-service contract research organization (CRO) for innovative trial management, is delighted to announce Andy Silverman, Ph.D., has joined its leadership team as

Catawba Research Finishes Move!

Catawba Research launched seven years ago. As we set out to build a world-class, full-service contract research organization, our journey quickly led us to many wonderful milestones. These accomplishments include dozens

Catawba Research Moves to Larger U.S. Headquarters

Catawba Research President and CEO Zaidoon A. Al-Zubaidy recently announced that the global CRO will relocate its home office operations to a larger space in the Charlotte, N.C. area. The news comes as the organization c

St. Cloud Capital Announces Investment In Catawba Research

St. Cloud Capital is pleased to announce an investment in Charlotte, North Carolina-based Catawba Research. St. Cloud has partnered with a financial investment firm focused on control investments in the life sciences and

Vyome Therapeutics Achieves Positive Results in Phase 2 Trial of VB-1953

Catawba Research is proud to have served as the CRO for Vyome Therapeutics on their successful Phase 2 Trial of VB-1953 for Moderate to Severe Acne. Needless to say, Catawba Research is excited for our client and honored

Meet Us at AAD & Experience Catawba Confidence in Your Next Trial!

Catawba Research Releases Teaser for Plaque Psoriasis Training Video

Here is a sample of our latest training video on plaque psoriasis with Dr. Zoe Draelos, a leader in clinical and research dermatology.

Catawba Research Adds Tinea Pedis Video to Training Library

To learn more about our training program or see some our videos, contact us !

Catawba Research Introduces New Training Video

Meet Your Dependable CRO with a Refreshing Approach

Catawba Research Brings Fresh Perspective to Clinical Trial Management

Over the last three years, Catawba Research has entered the pharmaceutical space to much industry attention. The North Carolina-based, multimillion dollar company has doubled its revenue and the number of studies initiat

The Importance of Site Relationships in Clinical Research

When it comes to clinical research, it goes without saying that the relationship between CRO and Sponsor is of utmost importance. Sponsors are footing the bill of the clinical trial and have specific timelines and delive

Corporate Responsibility

Over the past several years, we have witnessed our company, Catawba Research (Catawba), transform into a growing and prosperous CRO. We are very fortunate to experience such success, and as a part of our mission througho

Guerrilla Style Clinical Research

Running a clinical trial can feel a lot like going into battle. Planning a clinical trial is fraught with complex series of obstacles and potential pitfalls that must be expertly maneuvered to achieve victory. Along the

Catawba Research Concludes Another Rosacea Clinical Trial

Catawba Research is pleased to announce another achievement for a recently completed rosacea clinical trial. In this trial, Catawba enrolled more than 1000 rosacea subjects in 22 weeks from 33 sites .

Catawba Research Achieves Acne First-to-File

The team at Catawba Research has recently completed a first-to-file submission for acne clinical trial . In this study, Catawba enrolled a staggering 1125 acne vulgaris subjects in 8 weeks from 12 sites .

Won’t you get hip to this kindly tip, get your kicks on Route 505(b)(2). What is that?

Route 505(b)(2) vs. 505(j)

Catawba Research Introduces New Series of Training Videos

The quest for consistency in subjective clinical assessments, has led to the development of a number of grading methods to achieve data reliability. Whether it is the IGA, PASI, PGA or signs and symptoms scale to assess

An Overview of GDUFA

The Office of Generic Drugs (OGD) reports directly to the Director of the Center for Drug Evaluation and Research (CDER). The OGD’s mission is to ensure safe, effective, and affordable medicines for the American public.

How to Choose the Right CRO

Of all the big decisions to be made when conducting a clinical trial, perhaps the biggest of them all is selecting the right CRO for the job. With all the moving parts inherent in a trial, it is critical to find the righ